• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Jan Berger Discusses the Triple Aim and the Role of Retail Pharmacy

Article

Jan Berger, MD, MJ, President & CEO, Health Intelligence Partners, and editor-in-chief of The American Journal of Pharmacy Benefits, says the triple aim consists of cost, quality, and access. Additionally, the largest benefit that healthcare consumers can use is their health pharmacy benefit.

Jan Berger, MD, MJ, President & CEO, Health Intelligence Partners, and editor-in-chief of The American Journal of Pharmacy Benefits, says the triple aim consists of cost, quality, and access. Additionally, the largest benefit that healthcare consumers can use is their health pharmacy benefit.

“Utilizing the retail pharmacies as a point of access really can help address many of the factors in a triple aim,” Berger says.

Related Videos
Dr Susan Vadaparampil
Luke Messac at ISC 2026
Ava Liberman at ISC 2026
Alison Holman at ISC 2026
Dr Ameet Patel
Linda Stein Gold, MD
Dr. Emily Fisher at ISC 2026
Angelina Rose Wronski, RN, BS at ISC 2026
Margaret Krackeler, MD
Related Content
Drug pricing | Image Credit: © TarikVision-stock.adobe.com

TrumpRx Launch Brings Savings—and Uncertainty

February 5th 2026
Article

First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, with potential savings in the millions.

Read More

Managed Care Cast Square Image

The Orphan Drug Act in the Modern Drug Pricing Era

February 3rd 2026
Podcast

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Shervin Badihian at ISC 2026

How Apps and Wearable Tech Improve Life After Stroke: Shervin Badihian, MD

February 5th 2026
Article

Shervin Badihian, MD, explains how digital health tools can help boost poststroke activity via reminders, goals, feedback, and gamification.

Read More

managed care cast logo

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

January 27th 2026
Podcast

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

City St. George’s researcher Ateequllah Hayat, PhD, explains newly identified mechanisms behind lapatinib resistance in HER2-positive breast cancer.

New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD

February 4th 2026
Article

Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.

Read More

Prescription drugs on a money banknotes. Concept of healthcare costs - Vitalii - stock.adobe.com.jpeg

Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs

February 4th 2026
Article

Finance Committee leaders propose expanding Medicare negotiation, curbing middlemen, and reinvesting in biomedical innovation as part of a 2026 health care affordability strategy.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.